Medical Device Investing Pulse Biosciences Announces Clinical Data Highlighting its nPulse Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting
Medical Device Investing Pulse Biosciences Announces FDA IDE Approval to Initiate its nsPFA Cardiac Surgery System Study for the Treatment of Atrial Fibrillation
Medical Device Investing Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635
Medical Device Investing Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule Study
Angkor Resources Completes First Onshore Seismic Program in Cambodia; Vanderbilt Report Publishes Coverage
Troy Minerals Achieves Key Milestone Toward Operational Mining License for Its Tsagaan Zalaa Silica Project, Mongolia
